| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Selecta Biosciences Inc (NASDAQ: SELB)
SELB Technical Analysis
4
| As on 9th Jun 2023 SELB STOCK Price closed @ 1.32 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.70 & Strong Sell for SHORT-TERM with Stoploss of 2.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SELBSTOCK Price
| Open | 1.37 | Change | Price | % |
| High | 1.40 | 1 Day | -0.05 | -3.65 |
| Low | 1.31 | 1 Week | 0.17 | 14.78 |
| Close | 1.32 | 1 Month | 0.15 | 12.82 |
| Volume | 552900 | 1 Year | -1.95 | -59.63 |
| 52 Week High 3.57 | 52 Week Low 0.67 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SELB Daily Charts |
SELB Intraday Charts |
Whats New @ Bazaartrend |
SELB Free Analysis |
|
|
SELB Important Levels Intraday
| RESISTANCE | 1.49 |
| RESISTANCE | 1.44 |
| RESISTANCE | 1.40 |
| RESISTANCE | 1.37 |
| SUPPORT | 1.27 |
| SUPPORT | 1.24 |
| SUPPORT | 1.20 |
| SUPPORT | 1.15 |
SELB Forecast May 2024
| 4th UP Forecast | 3.15 |
| 3rd UP Forecast | 2.56 |
| 2nd UP Forecast | 2.2 |
| 1st UP Forecast | 1.84 |
| 1st DOWN Forecast | 0.8 |
| 2nd DOWN Forecast | 0.44 |
| 3rd DOWN Forecast | 0.08 |
| 4th DOWN Forecast | -0.51 |
SELB Weekly Forecast
| 4th UP Forecast | 2.09 |
| 3rd UP Forecast | 1.84 |
| 2nd UP Forecast | 1.69 |
| 1st UP Forecast | 1.54 |
| 1st DOWN Forecast | 1.10 |
| 2nd DOWN Forecast | 0.95 |
| 3rd DOWN Forecast | 0.80 |
| 4th DOWN Forecast | 0.55 |
SELB Forecast2024
| 4th UP Forecast | 7.08 |
| 3rd UP Forecast | 5.23 |
| 2nd UP Forecast | 4.09 |
| 1st UP Forecast | 2.95 |
| 1st DOWN Forecast | -0.31 |
| 2nd DOWN Forecast | -1.45 |
| 3rd DOWN Forecast | -2.59 |
| 4th DOWN Forecast | -4.44 |
Selecta Biosciences Inc ( NASDAQ USA Symbol : SELB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SELB Business Profile
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's proprietary pipeline includes enzymes therapies, gene therapies, and other products and product candidates affected by undesired immune responses. Its lead product is SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout, as well as develops a product candidate to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and IgA vasculitis. The company also engages in the development of gene therapy product candidates that are in preclinical development, including MMA-101, a product candidate for the treatment methylmalonic academia; SEL-313, a product candidate to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to indicate appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and other products for the treatment of pompe disease, duchenne muscular dystrophy, and limb-girdle muscular dystrophy. In addition, it develops a product candidate to treat primary biliary cholangitis. The company has license and collaboration agreements with Swedish Orphan Biovitrum; Spark Therapeutics; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Asklepios BioPharmaceutical, Inc. Sarepta Therapeutics, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts. Address: 65 Grove Street, Watertown, MA, United States, 02472
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service